Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death

International Journal of Hyperthermia

Volumn 24, Issue 8, 2008, Pages 638-648

  Park, Ho ^a   Cho, Jung Ah ^a   Kim, Suel Kee ^a   Kim, Jong Hoon ^a   Lee, Sang Hoon ^a  

^a Korea University   (South Korea)

Author keywords

Cancer therapy; Hyperthermia; Mesenchymal stem cells; Tumor stroma

Indexed keywords

AZACITIDINE; FAS ANTIGEN; FLUOROURACIL; GENISTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MULTIDRUG RESISTANCE PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER THERAPY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; RISK REDUCTION; SENSITIZATION; THERAPY EFFECT; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; HOT TEMPERATURE; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; NEOPLASM PROTEINS;

EID: 57649180522     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730802253117     Document Type: Article

References (43)

1. Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., Felix, R. and Schlag, PM (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol, 3, pp. 487-497.
2. von Ardenne, M. and Kruger, W. (1982) Combined whole-body and local hyperthermia for cancer treatment: CMT selectotherm technique. Prog Clin Biol Res, 107, pp. 705-713.
3. Overgaard, J. and Bichel, P. (1977) The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro. Radiology, 123, pp. 511-514.
4. Kang, MS, Song, CW and Levitt, SH (1980) Role of vascular function in response of tumors in vivo to hyperthermia. Cancer Res, 40, pp. 1130-1135.
5. Ohtsubo, T., Igawa, H., Saito, T., Matsumoto, H., Park, HJ, Song, CW, Kano, E. and Saito, H. (2001) Acidic environment modifies heat- or radiation-induced apoptosis in human maxillary cancer cells. Int J Radiat Oncol Biol Phys, 49, pp. 1391-1398.
6. Sawaji, Y., Sato, T., Takeuchi, A., Hirata, M. and Ito, A. (2002) Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer, 86, pp. 1597-1603.
7. Murata, T., Akagi, K., Imamura, M., Nasu, R., Kimura, H., Nagata, K. and Tanaka, K. (1998) Studies on hyperthermia combined with arterial therapeutic blockade for treatment of tumors: (Part III) Effectiveness of hyperthermia combined with arterial chemoembolization using degradable starch microspheres on advanced liver cancer. Oncol Rep, 5, pp. 709-712.
8. Ben-Yosef, R., Vigler, N., Inbar, M. and Vexler, A. (2004) Hyperthermia combined with radiation therapy in the treatment of local recurrent breast cancer. Isr Med Assoc, pp. 392-395.
9. Falk, MH and Issels, RD (2001) Hyperthermia in oncology. Int J Hyperthermia, 17, pp. 1-18.
10. Hegewisch-Becker, S. and Hossfeld, DK (2001) [Addition of hyperthermia. Heat potentiates cancer therapy]. MMW Fortschr Med, 143, pp. 28-32.
11. Roberts Jr., NJ (1991) Impact of temperature elevation on immunologic defenses. Rev Infect Dis, 13, pp. 462-472.
12. Conget, PA and Minguell, JJ (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol, 181, pp. 67-73.
13. Mageed, AS, Pietryga, DW, DeHeer, DH and West, RA (2007) Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: Characterization of fresh mesenchymal stem cells. Transplantation, 83, pp. 1019-1026.
14. Anokhina, EB and Burakova, LB (2007) [Heterogeneity of stromal precursor cells isolated from rat bone marrow]. Tsitologiia, 49, pp. 40-47.
15. Fierro, FA, Sierralta, WD, Epunan, MJ and Minguell, JJ (2004) Marrow-derived mesenchymal stem cells: Role in epithelial tumor cell determination. Clin Exp Metastasis, 21, pp. 313-319.
16. Studeny, M., Marini, FC, Dembinski, JL, Zompetta, C., Cabreira-Hansen, M., Bekele, BM, Champlin, RE and Andreeff, M. (2004) Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst, 96, pp. 1593-1603.
17. Karnoub, AE, Dash, AB, Vo, AP, Sullivan, A., Brooks, MW, Bell, GW, Richardson, AL, Polyak, K., Tubo, R. and Weinberg, RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449, pp. 557-563.
18. Hung, SC, Deng, WP, Yang, WK, Liu, RS, Lee, CC, Su, TC, Lin, RJ, Yang, DM, Chang, CW Chen, WH et al. (2005) Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res, 11, pp. 7749-7756.
19. Schichor, C., Birnbaum, T., Etminan, N., Schnell, O., Grau, S., Miebach, S., Aboody, K., Padovan, C., Straube, A. Tonn, JC et al. (2006) Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol, 199, pp. 301-310.
20. Detmar, M., Velasco, P., Richard, L., Claffey, KP, Streit, M., Riccardi, L., Skobe, M. and Brown, LF (2000) Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol, 156, pp. 159-167.
21. Alberti, C. (2006) Prostate cancer progression and surrounding microenvironment. Int J Biol Markers, 21, pp. 88-95.
22. Kopfstein, L. and Christofori, G. (2006) Metastasis: Cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci, 63, pp. 449-668.
23. Aggarwal, S. and Pittenger, MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, pp. 1815-1822.
24. Zhu, W., Xu, W., Jiang, R., Qian, H., Chen, M., Hu, J., Cao, W., Han, C. and Chen, Y. (2006) Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol, 80, pp. 267-274.
25. Hombauer, H. and Minguell, JJ (2000) Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer, 82, pp. 1290-1296.
26. Hall, B., Andreeff, M. and Marini, F. (2007) The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol, 180, pp. 263-283.
27. Knutson, KL and Disis, ML (2005) Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother, 54, pp. 721-728.
28. Marsters, SA, Pitti, RA, Sheridan, JP and Ashkenazi, A. (1999) Control of apoptosis signaling by Apo2 ligand. Recent Prog Horm Res, 54, pp. 225-234.
29. Gaspar, NJ, Li, L., Kapoun, AM, Medicherla, S., Reddy, M., Li, G., O'Young, G., Quon, D., Henson, M. Damm, DL et al. (2007) Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Mol Pharmacol, 72, pp. 152-161.
30. Jiang, EZ, Chang, YJ, Lee, JW, Lee, WK, Kim, JS, Sohn, SK, Lee, KB and Suh, JS (1998) Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: Correlations with CD surface markers and treatment outcome. J Korean Med Sci, 13, pp. 617-622.
31. Kitson, J., Raven, T., Jiang, YP, Goeddel, DV, Giles, KM, Pun, KT, Grinham, CJ, Brown, R. and Farrow, SN (1996) A death-domain-containing receptor that mediates apoptosis. Nature, 384, pp. 372-375.
32. Menon, LG, Picinich, S., Koneru, R., Gao, H., Lin, SY, Koneru, M., Mayer-Kuckuk, P., Glod, J. and Banerjee, D. (2007) Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells, 25, pp. 520-528.
33. Rowley, DR (1998) What might a stromal response mean to prostate cancer progression?. Cancer Metastasis Rev, 17, pp. 411-419.
34. Baronzio, G., Gramaglia, A. and Fiorentini, G. (2006) Hyperthermia and immunity. A brief overview. In vivo, 20, pp. 689-695.
35. Brown, EJ and Baltimore, D. (2003) Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev, 17, pp. 615-628.
36. Salti, GI, Grewal, S., Mehta, RR, Das Gupta, TK, Boddie Jr, AW and Constantinou, AI (2000) Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer, 36, pp. 796-802.
37. Hille, S., Rein, DT, Riffelmann, M., Neumann, R., Sartorius, J., Pfutzner, A., Kurbacher, CM, Schondorf, T. and Breidenbach, M. (2006) Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer. Anticancer Drugs', 17, pp. 1041-1044.
38. Vincent, T. and Mechti, N. (2005) Extracellular matrix in bone marrow can mediate drug resistance in myeloma. Leuk Lymphoma, 46, pp. 803-811.
39. Bubenik, J. (2003) Tumour MHC class I downregulation and immunotherapy (Review). Oncol Rep, 10, pp. 2005-2008.
40. Marten, A., Ziske, C., Schottker, B., Weineck, S., Renoth, S., Buttgereit, P., Schakowski, F., Konig, S., von Rucker, A. Allera, A. et al. (2001) Transfection of dendritic cells (DCs) with the CIITA gene: Increase in immunostimulatory activity of DCs. Cancer Gene Ther, 8, pp. 211-219.
41. Chaperot, L., Jacob, MC, Molens, JP, Manches, O., Bensa, JC and Plumas, J. (2000) From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas. Leuk Lymphoma, 38, pp. 247-263.
42. Rumsaeng, V., Cruikshank, WW, Foster, B., Prussin, C., Kirshenbaum, AS, Davis, TA, Kornfeld, H., Center, DM and Metcalfe, DD (1997) Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol, 159, pp. 2904-2910.
43. Song, HL, Lu, S. and Liu, P. (2005) [Tumor necrosis factor alpha and enterocyte apoptosis in mice with fulminant hepatic failure.]. Zhonghua Gan Zang Bing Za Zhi, 13, pp. 290-293.